Back

Secretoneurin plasma levels are decreased after catheter ablation for atrial fibrillation, patients with AF produce lower SN levels than healthy individuals

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Predicting outcomes after catheter ablation for atrial fibrillation: ablation technique, biomarkers, and machine learning Diagnostic Methods ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Jiri Plasek

University Hospital Ostrava, Ostrava (Czechia)

8 More presentations in this session

Presentation thumbnail
Prediction of atrial fibrillation recurrence after ablation: the impact of machine learning and recurrence during the blanking period
Doctor J. Almeida (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Long-term prognosis in patients undergoing atrial fibrillation ablation
Doctor M. Kiliszek (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Biomarkers in early and late period after radiofrequency and pulsed field catheter ablation of atrial fibrillation
Miss B. Stekla (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Ppulsed field ablation and ultra-high-density mapping for PVI: use of machine learning and data augmentation to guide procedure and identify recurrent tachycardia mechanisms at one-year follow-up
Doctor S. Feickert (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
An in-silico comparison of anatomical and substrate based AF ablation using electro and optical flow mapping
Mr O. Jaffery (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting outcomes after catheter ablation for atrial fibrillation: ablation technique, biomarkers, and machine learning

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The neuropetide secretoneurin in STEMI patients: association with major adverse cardiovascular events
thumbnail
Congress Presentation
Atrial fibrillation is perpetuated by human heart secretome in ex-vivo langendorff-perfused hearts.
thumbnail
Congress Presentation
Clinical determinants of blood biomarkers of atrial cardiomyopathy: results from the ISOLATION AF ablation cohort study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources